スタッフ紹介詳細
Yoshiaki Murakami, MD, Ph.D. E-mail mura777@hiroshima-u.ac.jp
Medical School
1983 Hiroshima University, Hiroshima, MD 1994 Hiroshima University, Hiroshima, Ph.D.
Residency
1983 Resident in Surgery, Hiroshima University Hospital, Hiroshima
Fellowship
1992 Minessota Univsersity, MN 1994 Hiroshima University, Assistant professor 2011 Hiroshima University, Associate professor of Surgery
Speciality
Gastrointestinal Surgery, Hepato-Biliary-Pancreatic Surgery, Surgical Oncology
Research interest
Pancreatic Cancer, Biliary Cancer
Certification
Academic Rank
Associate professor of Surgery
Publications
See a listing of publications on PubMed, a service of the National Library of medicine.
Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Kondo N, Sakabe R, Kobayashi H, Sueda T. Prognostic factors of patients with advanced gallbladder carcinoma following aggressive surgical resection. J Gastrointest Surg. 2011 Jun;15(6):1007-16. Epub 2011 Mar 10.
Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Kondo N, Sakabe R, Kobayashi H, Sueda T. Is para-aortic lymph node metastasis a contraindication for radical resection in biliary carcinoma? World J Surg. 2011 May;35(5):1085-93.
Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Kondo N, Sakabe R, Ohge H, Sueda T. Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol. 2011 Mar;18(3):651-8. Epub 2010 Oct 14.
Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakashima A, Yuasa Y, Kondo N, Ohge H, Sueda T. Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma. J Am Coll Surg. 2010 Aug;211(2):196-204. Epub 2010 Jun 8.
Murakami Y, Uemura K, Sudo T, Hashimoto Y, Yuasa Y, Sueda T. Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma. World J Surg. 2010 Aug;34(8):1900-7.
Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakamura H, Nakashima A, Sueda T. Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma. Ann Surg. 2009 Dec;250(6):950-6.
Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakamura H, Nakashima A, Sueda T. Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma. J Gastrointest Surg. 2009 Aug;13(8):1470-9. Epub 2009 May 7.
Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakashima A, Sueda T. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma. J Surg Oncol. 2009 Jul 1;100(1):13-8.
Murakami Y, Uemura K, Hayasidani Y, Sudo T, Hashimoto Y, Ohge H, Sueda T. Indication for postoperative adjuvant therapy in biliary carcinoma based on analysis of recurrence and survival after surgical resection. Dig Dis Sci. 2009 Jun;54(6):1360-4. Epub 2008 Oct 31.
Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Ohge H, Sueda T. Impact of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for adenocarcinoma of the body or tail of the pancreas. J Gastrointest Surg. 2009 Jan;13(1):85-92. Epub 2008 Aug 13.
Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakagawa N, Ohge H,Sueda T.Adjuvant gemcitabine plus S-1 chemotherapy after surgical resection forpancreatic adenocarcinoma. Am J Surg. 2008 Jun;195(6):757-62.
Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Ohge H, Sueda T.Long-term pancreatic endocrine function following pancreatoduodenectomy with pancreaticogastrostomy. J Surg Oncol. 2008 May 1;97(6):519-22. Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakagawa N, Ohge H,Sueda T.An Antecolic Roux-en Y type Reconstruction Decreased Delayed Gastric Emptying after Pylorus-Preserving Pancreatoduodenectomy. J Gastrointest Surg. 2008 Jun;12(6):1081-6. Epub 2008 Feb 7.
Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Nakagawa N, Ohge H,Sueda T. No mortality after 150 consecutive pancreatoduodenctomies with duct-to-mucosa pancreaticogastrostomy. J Surg Oncol. 2008 Mar 1;97(3):205-9.
Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Ohge H, Sueda T. Postoperative adjuvant chemotherapy improves survival after surgical resection for pancreatic carcinoma. J Gastrointest Surg. 2008 Mar;12(3):534-41. Epub 2007 Nov 17.
Murakami Y, Uemura K, Hayasidani Y, Sudo T, Hashimoto Y, Nakagawa N, Ohge H, Sueda T.A soft pancreatic remnant is associated with increased drain fluid pancreatic amylase and serum CRP levels following pancreatoduodenectomy. J Gastrointest Surg. 2008 Jan;12(1):51-6. Epub 2007 Oct 23.
Murakami Y, Uemura K, Hayashidani Y, Sudo T, Sueda T. Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas. J Gastrointest Surg. 2007 Mar;11(3):338-44.
Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Ohge H, Sueda T. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma. J Surg Oncol. 2007 Mar 1;95(3):207-12.
Murakami Y, Uemura K, Hayashidani Y, Sudo T, Ohge H, Sueda T. Pancreatoduodenectomy for distal cholangiocarcinoma: prognostic impact of lymph node metastasis. World J Surg. 2007 Feb;31(2):337-42; discussion 343-4.
Murakami Y, Uemura K, Ohge H, Hayashidani Y, Sudo T, Sueda T. Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma. Surgery. 2006 Sep;140(3):448-53. Epub 2006 Jul 27.
Murakami Y, Uemura K, Hayashidani Y, Sudo T, Sueda T. Relapsing acute pancreatitis due to ampullary adenoma in a patient with familial adenomatous polyposis. J Gastroenterol. 2006 Aug;41(8):798-801.
Murakami Y, Uemura K, Morifuji M, Hayashidani Y, Sudo T, Sueda T. Mucinous cystic neoplasm of the pancreas with ovarian-type stroma arising in the head of the pancreas: case report and review of the literature. Dig Dis Sci. 2006 Mar;51(3):629-32. Review. No abstract available.
Murakami Y, Kanehiro T, Yokoyama Y, Uemura K, Sasaki M, Morifuji M, Hayashidani Y, Sudo T, Sueda T. Successful complete resection of biliary cystadenocarcinoma after percutaneoustranshepatic portal embolization. Surgery. 2005 May;137(5):577-9. No abstract available.
Murakami Y, Uemura K, Sasaki M, Morifuji M, Hayashidani Y, Sudo T, Sueda T. Duodenal cancer arising from the remaining duodenum after pylorus-preserving pancreatoduodenectomy for ampullary cancer in familial adenomatous polyposis. J Gastrointest Surg. 2005 Mar;9(3):389-92.
Murakami Y, Uemura K, Yokoyama Y, Sasaki M, Morifuji M, Hayashidani Y, Sudo T, Sueda T. Pancreatic head resection with segmental duodenectomy for intraductal papillary mucinous tumors of the pancreas. J Gastrointest Surg. 2004 Sep-Oct;8(6):713-9.
Murakami Y, Uemura K, Yokoyama Y, Sasaki M, Morifuji M, Hayashidani Y, Sudo T, Sueda T. Celiac axis occlusion with replaced common hepatic artery and pancreatoduodenectomy. J Gastrointest Surg. 2004 May-Jun;8(4):520-2.
Murakami Y, Yokoyama T, Kanehiro T, Uemura K, Sasaki M, Morifuji M, Sueda T. Successful diagnosis and resection of icteric type hepatocellular carcinoma. Hepatogastroenterology. 2003 Sep-Oct;50(53):1634-6.
Murakami Y, Yokoyama T, Yokoyama Y, Kanehiro T, Uemura K, Sasaki M, Morifuji M, Sueda T. Adenosquamous carcinoma of the pancreas: preoperative diagnosis and molecular alterations. J Gastroenterol. 2003;38(12):1171-5.
Murakami Y, Yokoyama T, Hiyama E, Yokoyama Y, Kanehiro T, Uemura K, Sasaki M, Morifuji M, Sueda T. Successful pre-operative diagnosis of malignant intraductal papillary mucinous tumor of the pancreas by detecting telomerase activity. Int J Gastrointest Cancer. 2002;31(1-3):117-21.
etc.
|